| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Institute of Pathology,
Clinics of Physical Medicine and Rehabilitation, and
Institute of Medical Immunology, Charité, Humboldt University, Berlin, Germany; and
§ Ethel Percy Andrus Gerontology Center and Division of Molecular Biology, the University of Southern California, Los Angeles, California 90089-0191, USA
1Correspondence: Ethel Percy Andrus Gerontology Center, University of Southern California, 3715 McClintock Ave., Room 306, Los Angeles, CA 90089-0191, USA. E-mail: kelvin{at}usc.edu
We have studied the effects of hyperoxia and of cell loading with artificial lipofuscin or ceroid pigment on the postmitotic aging of human lung fibroblast cell cultures. Normobaric hyperoxia (40% oxygen) caused an irreversible senescence-like growth arrest after about 4 wk and shortened postmitotic life span from 1–1/2 years down to 3 months. During the first 8 wk of hyperoxia-induced ‘aging’, overall protein degradation (breakdown of [35S]methionine metabolically radiolabeled cell proteins) increased somewhat, but by 12 wk and thereafter overall proteolysis was significantly depressed. In contrast, protein synthesis rates were unaffected by 12 wk of hyperoxia. Lysosomal cathepsin-specific activity (using the fluorogenic substrate z-FR-MCA) and cytoplasmic proteasome-specific activity (measured with suc-LLVY-MCA) both declined by 80% or more over 12 wk. Hyperoxia also caused a remarkable increase in lipofuscin/ceroid formation and accumulation over 12 wk, as judged by both fluorescence measurements and FACscan methods. To test whether the association between lipofuscin/ceroid accumulation and decreased proteolysis might be causal, we next exposed cells to lipofuscin/ceroid loading under normoxic conditions. Lipofuscin/ceroid-loaded cells indeed exhibited a gradual decrease in overall protein degradation over 4 wk of treatment, whereas protein synthesis was unaffected. Proteasome specific activity decreased by 25% over this period, which is important since proteasome is normally responsible for degrading oxidized cell proteins. In contrast, an apparent increase in lysosomal cathepsin activity was actually caused by a large increase in the number of lysosomes per cell. To test whether lipofuscin/ceroid could in fact directly inhibit proteasome activity, thus causing oxidized proteins to accumulate, we incubated purified proteasome with lipofuscin/ceroid preparations in vitro. We found that proteasome is directly inhibited by lipofuscin/ceroid. Our results indicate that an accumulation of oxidized proteins (and lipids) such as lipofuscin/ceroid may actually cause further increases in damage accumulation during aging by inhibiting the proteasome.—Sitte, N., Huber, M., Grune, T., Ladhoff, A., Doecke, W.-D., von Zglinicki, T., Davies, K. J. A. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts.
Key Words: ceroid pigment • protein turnover • lysosome • oxidative stress • free radicals
This article has been cited by other articles:
|
|
 |
|
  E. V. Ilieva, V. Ayala, M. Jove, E. Dalfo, D. Cacabelos, M. Povedano, M. J. Bellmunt, I. Ferrer, R. Pamplona, and M. Portero-Otin Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis Brain, December 1, 2007; 130(12): 3111 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. AHMED, C. R. PICOT, A.-L. BULTEAU, and B. FRIGUET Protein Oxidative Modifications and Replicative Senescence of WI-38 Human Embryonic Fibroblasts Ann. N.Y. Acad. Sci., November 1, 2007; 1119(1): 88 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. JUNG, N. BADER, and T. GRUNE Lipofuscin: Formation, Distribution, and Metabolic Consequences Ann. N.Y. Acad. Sci., November 1, 2007; 1119(1): 97 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Zolk, C. Schenke, and A. Sarikas The ubiquitin-proteasome system: Focus on the heart Cardiovasc Res, June 1, 2006; 70(3): 410 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani Biomarkers of Oxidative Damage in Human Disease Clin. Chem., April 1, 2006; 52(4): 601 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J.A. Davies and R. Shringarpure Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases Neurology, January 24, 2006; 66(1_suppl_1): S93 - S96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Gray and J. Woulfe Lipofuscin and Aging: A Matter of Toxic Waste Sci. Aging Knowl. Environ., February 2, 2005; 2005(5): re1 - re1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hamatani, G. Falco, M. G. Carter, H. Akutsu, C. A. Stagg, A. A. Sharov, D. B. Dudekula, V. VanBuren, and M. S.H. Ko Age-associated alteration of gene expression patterns in mouse oocytes Hum. Mol. Genet., October 1, 2004; 13(19): 2263 - 2278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Sullivan, N. B. Dragicevic, J.-H. Deng, Y. Bai, E. Dimayuga, Q. Ding, Q. Chen, A. J. Bruce-Keller, and J. N. Keller Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover J. Biol. Chem., May 14, 2004; 279(20): 20699 - 20707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Martin-Ruiz, G. Saretzki, J. Petrie, J. Ladhoff, J. Jeyapalan, W. Wei, J. Sedivy, and T. von Zglinicki Stochastic Variation in Telomere Shortening Rate Causes Heterogeneity of Human Fibroblast Replicative Life Span J. Biol. Chem., April 23, 2004; 279(17): 17826 - 17833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Jara, R Carballada, and P Esponda Age-induced apoptosis in the male genital tract of the mouse Reproduction, March 1, 2004; 127(3): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Welle, A. I. Brooks, J. M. Delehanty, N. Needler, and C. A. Thornton Gene expression profile of aging in human muscle Physiol Genomics, July 7, 2003; 14(2): 149 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. GRUNE, T. REINHECKEL, J. A. NORTH, R. LI, P. B. BESCOS, R. SHRINGARPURE, and K. J. A. DAVIES Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells FASEB J, October 1, 2002; 16(12): 1602 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. HIPKISS, C. BROWNSON, M. F. BERTANI, E. RUIZ, and A. FERRO Reaction of Carnosine with Aged Proteins: Another Protective Process? Ann. N.Y. Acad. Sci., April 1, 2002; 959(1): 285 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Droge Free Radicals in the Physiological Control of Cell Function Physiol Rev, January 1, 2002; 82(1): 47 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Bulteau, P. Verbeke, I. Petropoulos, A.-F. Chaffotte, and B. Friguet Proteasome Inhibition in Glyoxal-treated Fibroblasts and Resistance of Glycated Glucose-6-phosphate Dehydrogenase to 20 S Proteasome Degradation in Vitro J. Biol. Chem., November 30, 2001; 276(49): 45662 - 45668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Grune, R. Shringarpure, N. Sitte, and K. Davies Age-Related Changes in Protein Oxidation and Proteolysis in Mammalian Cells J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2001; 56(11): B459 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Bulteau, K. C. Lundberg, K. M. Humphries, H. A. Sadek, P. A. Szweda, B. Friguet, and L. I. Szweda Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion J. Biol. Chem., August 3, 2001; 276(32): 30057 - 30063. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
